Kymera Therapeutics (KYMR) EV to CFO (2020 - 2021)
Kymera Therapeutics' (KYMR) EV to CFO stood at 31.57 in Q2 2021, up 73.1% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) EV to CFO (2020 - 2021) Analysis & Trends
On a TTM basis, Kymera Therapeutics' EV to CFO came in at 15.72 as of Jun 30, 2021; for FY2020, it was 8.84.
- Per Business Quant, the preceding three quarters came in at 18.23 (Q1 2021), 8.84 (Q4 2020) and 3.84 (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 31.57 |
| Mar 31, 2021 | 18.23 |
| Dec 31, 2020 | 8.84 |
| Sep 30, 2020 | 3.84 |
API Access
Kymera Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();